MRRS adds "Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (fevers) and weight loss. Treatment includes chemotherapy and radiation therapy.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Bile Duct Cancer (Cholangiocarcinoma) (Oncology).
– The pipeline guide reviews pipeline therapeutics for Bile Duct Cancer (Cholangiocarcinoma) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Bile Duct Cancer (Cholangiocarcinoma) (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Bile Duct Cancer (Cholangiocarcinoma) (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Bile Duct Cancer (Cholangiocarcinoma) (Oncology)

Table Of Contents
Table of Contents 2
Introduction 6
Bile Duct Cancer (Cholangiocarcinoma) Overview 7
Therapeutics Development 8
Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics under Development by Companies 10
Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics under Investigation by Universities/Institutes 14
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Products Glance 15
Bile Duct Cancer (Cholangiocarcinoma) - Products under Development by Companies 18
Bile Duct Cancer (Cholangiocarcinoma) - Products under Investigation by Universities/Institutes 23
Bile Duct Cancer (Cholangiocarcinoma) - Companies Involved in Therapeutics Development 24
Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics Assessment 87
Drug Profiles 101
Bile Duct Cancer (Cholangiocarcinoma) - Dormant Projects 464
Bile Duct Cancer (Cholangiocarcinoma) - Discontinued Products 467
Bile Duct Cancer (Cholangiocarcinoma) - Product Development Milestones 468
Appendix 481
....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/bile-duct-cancer-cholangiocarcinoma-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.